Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Corrigendum. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.

Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morré SA, de Jonge JD, Poort L, Cuypers WJSS, Beckers NGM, Broekmans FJM, Cohlen BJ, den Hartog JE, Fleischer K, Lambalk CB, Smeenk JMJS, Budding AE, Laven JSE.

Hum Reprod. 2019 Jul 12. pii: dez127. doi: 10.1093/humrep/dez127. [Epub ahead of print] No abstract available.

PMID:
31299066
2.

The Potential Role for Host Genetic Profiling in Screening for Chlamydia-Associated Tubal Factor Infertility (TFI)-New Perspectives.

Malogajski J, Branković I, Land JA, Thomas PPM, Morré SA, Ambrosino E.

Genes (Basel). 2019 May 28;10(6). pii: E410. doi: 10.3390/genes10060410.

3.

The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.

Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morré SA, de Jonge JD, Poort L, Cuypers WJSS, Beckers NGM, Broekmans FJM, Cohlen BJ, den Hartog JE, Fleischer K, Lambalk CB, Smeenk JMJS, Budding AE, Laven JSE.

Hum Reprod. 2019 Jun 4;34(6):1042-1054. doi: 10.1093/humrep/dez065.

PMID:
31119299
4.

The relation of the vaginal microbiota to early pregnancy development during in vitro fertilization treatment-A meta-analysis.

Singer M, Borg M, Ouburg S, Morré SA.

J Gynecol Obstet Hum Reprod. 2019 Apr;48(4):223-229. doi: 10.1016/j.jogoh.2019.01.007. Epub 2019 Jan 24.

PMID:
30685426
5.

Combining individual Chlamydia trachomatis IgG antibodies MOMP, TARP, CPAF, OMP2, and HSP60 for tubal factor infertility prediction.

van Ess EF, Eck-Hauer A, Land JA, Morré SA, Ouburg S.

Am J Reprod Immunol. 2019 Mar;81(3):e13091. doi: 10.1111/aji.13091. Epub 2019 Feb 6.

6.

Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial.

Hoenderboom BM, van Benthem BHB, van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA, Hogewoning AA, Land JA, van der Sande MAB, Morré SA, van den Broek IVF.

Sex Transm Infect. 2019 Jun;95(4):300-306. doi: 10.1136/sextrans-2018-053778. Epub 2019 Jan 3.

7.

The ReceptIVFity cohort study protocol to validate the urogenital microbiome as predictor for IVF or IVF/ICSI outcome.

Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morré SA, de Jonge JD, Poort L, Cuypers WSS, Budding AE, Laven JSE; ReceptIVFity study group.

Reprod Health. 2018 Dec 7;15(1):202. doi: 10.1186/s12978-018-0653-x.

8.

An Integrated Care Model With Implementation Roadmap to Improve Chlamydia trachomatis Management and Control in India.

Thomas PPM, Allam RR, Ambrosino E, Malogajski J, Lal JA, Morré SA, Peters RPH.

Front Public Health. 2018 Nov 9;6:321. doi: 10.3389/fpubh.2018.00321. eCollection 2018.

9.

Provision of Sexually Transmitted Infection Services in a Mobile Clinic Reveals High Unmet Need in Remote Areas of South Africa: A Cross-sectional Study.

Hoffman CM, Mbambazela N, Sithole P, Morré SA, Dubbink JH, Railton J, McIntyre JA, Kock MM, Peters RPH.

Sex Transm Dis. 2019 Mar;46(3):206-212. doi: 10.1097/OLQ.0000000000000931.

PMID:
30363030
10.

Development of a rapid colorimetric multiplex PCR-reverse line blot for the detection and typing of 14 Chlamydia trachomatis genovars.

Molano M, Tabrizi SN, Phillips S, Danielewski J, Cornall A, Morre SA, Garland SM.

J Med Microbiol. 2018 Oct 10. doi: 10.1099/jmm.0.000836. [Epub ahead of print]

PMID:
30303481
11.

Optimising SME Potential in Modern Healthcare Systems: Challenges, Opportunities and Policy Recommendations.

Horgan D, van Kranen HJ, Morré SA.

Public Health Genomics. 2018;21(1-2):1-17. doi: 10.1159/000492809. Epub 2018 Aug 24. Review.

12.

Pathway-Wide Genetic Risks in Chlamydial Infections Overlap between Tissue Tropisms: A Genome-Wide Association Scan.

Roberts CH, Ouburg S, Preston MD, de Vries HJC, Holland MJ, Morré SA.

Mediators Inflamm. 2018 Jun 3;2018:3434101. doi: 10.1155/2018/3434101. eCollection 2018.

13.

Comparison of the Mikrogen multi-target ELISA with the Mikrogen recomLine immunoblot for the detection of Chlamydia trachomatis IgG antibodies in serum in infertile women.

van Ess EF, Ouburg S, Land JA, Morré SA.

J Microbiol Methods. 2018 Jul;150:5-8. doi: 10.1016/j.mimet.2018.05.006. Epub 2018 May 7.

14.

Genital Chlamydia trachomatis and Neisseria gonorrhoeae infections among women in sub-Saharan Africa: A structured review.

Dubbink JH, Verweij SP, Struthers HE, Ouburg S, McIntyre JA, Morré SA, Peters RP.

Int J STD AIDS. 2018 Jul;29(8):806-824. doi: 10.1177/0956462418758224. Epub 2018 Feb 28. Review.

PMID:
29486628
15.

Genetic predisposition to infection in a case of atypical hemolytic uremic syndrome.

van den Heuvel L, Riesbeck K, El Tahir O, Gracchi V, Kremlitzka M, Morré SA, van Furth AM, Singh B, Okrój M, van de Kar N, Blom AM, Volokhina E.

J Hum Genet. 2018 Jan;63(1):93-96. doi: 10.1038/s10038-017-0356-0. Epub 2017 Nov 13.

PMID:
29215086
16.

Chlamydia trachomatis antibody detection in home-collected blood samples for use in epidemiological studies.

Hoenderboom BM, van Ess EF, van den Broek IVF, van Loo IHM, Hoebe CJPA, Ouburg S, Morré SA.

J Microbiol Methods. 2018 Jan;144:164-167. doi: 10.1016/j.mimet.2017.11.022. Epub 2017 Nov 28.

17.

Chlamydia trachomatis Strain Types Have Diversified Regionally and Globally with Evidence for Recombination across Geographic Divides.

Smelov V, Vrbanac A, van Ess EF, Noz MP, Wan R, Eklund C, Morgan T, Shrier LA, Sanders B, Dillner J, de Vries HJC, Morre SA, Dean D.

Front Microbiol. 2017 Nov 13;8:2195. doi: 10.3389/fmicb.2017.02195. eCollection 2017.

18.

Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial.

Tamarelle J, Thiébaut ACM, Sabin B, Bébéar C, Judlin P, Fauconnier A, Rahib D, Méaude-Roufai L, Ravel J, Morré SA, de Barbeyrac B, Delarocque-Astagneau E; i-Predict study group.

Trials. 2017 Nov 13;18(1):534. doi: 10.1186/s13063-017-2211-1.

19.

Prevalence of Trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study.

de Waaij DJ, Dubbink JH, Ouburg S, Peters RPH, Morré SA.

BMJ Open. 2017 Oct 8;7(10):e016959. doi: 10.1136/bmjopen-2017-016959.

20.
21.

Prevalence of genital Chlamydia trachomatis infections in Russia: systematic literature review and multicenter study.

Smelov V, Thomas P, Ouburg S, Morré SA.

Pathog Dis. 2017 Sep 29;75(7). doi: 10.1093/femspd/ftx081. Review.

PMID:
28830072
22.

Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansion.

Hadfield J, Harris SR, Seth-Smith HMB, Parmar S, Andersson P, Giffard PM, Schachter J, Moncada J, Ellison L, Vaulet MLG, Fermepin MR, Radebe F, Mendoza S, Ouburg S, Morré SA, Sachse K, Puolakkainen M, Korhonen SJ, Sonnex C, Wiggins R, Jalal H, Brunelli T, Casprini P, Pitt R, Ison C, Savicheva A, Shipitsyna E, Hadad R, Kari L, Burton MJ, Mabey D, Solomon AW, Lewis D, Marsh P, Unemo M, Clarke IN, Parkhill J, Thomson NR.

Genome Res. 2017 Jul;27(7):1220-1229. doi: 10.1101/gr.212647.116. Epub 2017 Jun 6.

23.

Burden of Chlamydia trachomatis in India: a systematic literature review.

Thomas P, Spaargaren J, Kant R, Lawrence R, Dayal A, Lal JA, Morré SA.

Pathog Dis. 2017 Jul 31;75(5). doi: 10.1093/femspd/ftx055. Review.

24.

The attitudes of Dutch fertility specialists towards the addition of genetic testing in screening of tubal factor infertility.

Malogajski J, Jansen ME, Ouburg S, Ambrosino E, Terwee CB, Morré SA.

Sex Reprod Healthc. 2017 Jun;12:123-127. doi: 10.1016/j.srhc.2017.04.001. Epub 2017 Apr 5.

PMID:
28477924
25.

Concern regarding the alleged spread of hypervirulent lymphogranuloma venereum Chlamydia trachomatis strain in Europe.

Seth-Smith HM, Galán JC, Goldenberger D, Lewis DA, Peuchant O, Bébéar C, de Barbeyrac B, Bénard A, Carter I, Kok J, Bruisten SM, Versteeg B, Morré SA, Thomson NR, Egli A, de Vries HJ.

Euro Surveill. 2017 Apr 13;22(15). pii: 30511. doi: 10.2807/1560-7917.ES.2017.22.15.30511. No abstract available.

26.

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Hoenderboom BM, van Oeffelen AA, van Benthem BH, van Bergen JE, Dukers-Muijrers NH, Götz HM, Hoebe CJ, Hogewoning AA, van der Klis FR, van Baarle D, Land JA, van der Sande MA, van Veen MG, de Vries F, Morré SA, van den Broek IV.

BMC Infect Dis. 2017 Apr 11;17(1):264. doi: 10.1186/s12879-017-2376-y.

27.

Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.

Mehta AM, Mooij M, Branković I, Ouburg S, Morré SA, Jordanova ES.

J Immunol Res. 2017;2017:8913860. doi: 10.1155/2017/8913860. Epub 2017 Feb 9. Review.

28.

Design of the FemCure study: prospective multicentre study on the transmission of genital and extra-genital Chlamydia trachomatis infections in women receiving routine care.

Dukers-Muijrers NH, Wolffs PF, Eppings L, Götz HM, Bruisten SM, Schim van der Loeff MF, Janssen K, Lucchesi M, Heijman T, van Benthem BH, van Bergen JE, Morre SA, Herbergs J, Kok G, Steenbakkers M, Hogewoning AA, de Vries HJ, Hoebe CJ.

BMC Infect Dis. 2016 Aug 8;16:381. doi: 10.1186/s12879-016-1721-x.

29.

Sexual behaviour of women in rural South Africa: a descriptive study.

Dubbink JH, van der Eem L, McIntyre JA, Mbambazela N, Jobson GA, Ouburg S, Morre SA, Struthers HE, Peters RP.

BMC Public Health. 2016 Jul 12;16:557. doi: 10.1186/s12889-016-3207-6.

30.

Evaluation of syndromic management guidelines for treatment of sexually transmitted infections in South African women.

van der Eem L, Dubbink JH, Struthers HE, McIntyre JA, Ouburg S, Morré SA, Kock MM, Peters RP.

Trop Med Int Health. 2016 Sep;21(9):1138-46. doi: 10.1111/tmi.12742. Epub 2016 Jul 19.

31.

Evaluation of Presto(plus) assay and LightMix kit Trichomonas vaginalis assay for detection of Trichomonas vaginalis in dry vaginal swabs.

de Waaij DJ, Ouburg S, Dubbink JH, Peters RPH, Morré SA.

J Microbiol Methods. 2016 Aug;127:102-104. doi: 10.1016/j.mimet.2016.06.002. Epub 2016 Jun 3.

32.

Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study.

Alberts CJ, Vos RA, Borgdorff H, Vermeulen W, van Bergen J, Bruisten SM, Geerlings SE, Snijder MB, van Houdt R, Morré SA, de Vries HJ, van de Wijgert JH, Prins M, Schim van der Loeff MF.

Sex Transm Infect. 2016 Dec;92(8):611-618. doi: 10.1136/sextrans-2015-052397. Epub 2016 May 17.

PMID:
27188273
33.

Host Polymorphisms in TLR9 and IL10 Are Associated With the Outcomes of Experimental Haemophilus ducreyi Infection in Human Volunteers.

Singer M, Li W, Morré SA, Ouburg S, Spinola SM.

J Infect Dis. 2016 Aug 1;214(3):489-95. doi: 10.1093/infdis/jiw164. Epub 2016 Apr 27.

34.

Specific polymorphisms in the vitamin D metabolism pathway are not associated with susceptibility to Chlamydia trachomatis infection in humans.

Lanjouw E, Branković I, Pleijster J, Spaargaren J, Hoebe CJ, van Kranen HJ, Ouburg S, Morré SA.

Pathog Dis. 2016 Apr;74(3). pii: ftw010. doi: 10.1093/femspd/ftw010. Epub 2016 Feb 10.

35.

Potential protective effect of a G>A SNP in the 3'UTR of HLA-A for Chlamydia trachomatis symptomatology and severity of infection.

Jansen ME, Branković I, Spaargaren J, Ouburg S, Morré SA.

Pathog Dis. 2016 Mar;74(2). pii: ftv116. doi: 10.1093/femspd/ftv116. Epub 2015 Dec 9.

36.

Assessment of Chlamydia suis Infection in Pig Farmers.

De Puysseleyr L, De Puysseleyr K, Braeckman L, Morré SA, Cox E, Vanrompay D.

Transbound Emerg Dis. 2017 Jun;64(3):826-833. doi: 10.1111/tbed.12446. Epub 2015 Nov 18.

PMID:
26576707
37.

TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women.

Verweij SP, Karimi O, Pleijster J, Lyons JM, de Vries HJ, Land JA, Morré SA, Ouburg S.

Pathog Dis. 2016 Feb;74(1):ftv107. doi: 10.1093/femspd/ftv107. Epub 2015 Nov 13.

38.

Microbiological Characteristics of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in South African Women.

Dubbink JH, de Waaij DJ, Bos M, van der Eem L, Bébéar C, Mbambazela N, Ouburg S, Peters RP, Morré SA.

J Clin Microbiol. 2016 Jan;54(1):200-3. doi: 10.1128/JCM.02848-15. Epub 2015 Oct 28.

39.

Serological Screening for Celiac Disease in Adult Chinese Patients With Diarrhea Predominant Irritable Bowel Syndrome.

Wang H, Zhou G, Luo L, Crusius JB, Yuan A, Kou J, Yang G, Wang M, Wu J, von Blomberg BM, Morré SA, Peña AS, Xia B.

Medicine (Baltimore). 2015 Oct;94(42):e1779. doi: 10.1097/MD.0000000000001779.

40.

Waddlia chondrophila and Chlamydia trachomatis antibodies in screening infertile women for tubal pathology.

Verweij SP, Kebbi-Beghdadi C, Land JA, Ouburg S, Morré SA, Greub G.

Microbes Infect. 2015 Nov-Dec;17(11-12):745-8. doi: 10.1016/j.micinf.2015.09.019. Epub 2015 Sep 30.

PMID:
26428856
41.

Comparison of GMT presto assay and Roche cobas® 4800 CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in dry swabs.

de Waaij DJ, Dubbink JH, Peters RP, Ouburg S, Morré SA.

J Microbiol Methods. 2015 Nov;118:70-4. doi: 10.1016/j.mimet.2015.08.020. Epub 2015 Aug 29.

PMID:
26327539
42.

CpG DNA analysis of bacterial STDs.

Singer M, de Waaij DJ, Morré SA, Ouburg S.

BMC Infect Dis. 2015 Jul 16;15:273. doi: 10.1186/s12879-015-1016-7.

43.

NOD1 in contrast to NOD2 functional polymorphism influence Chlamydia trachomatis infection and the risk of tubal factor infertility.

Branković I, van Ess EF, Noz MP, Wiericx WA, Spaargaren J, Morré SA, Ouburg S.

Pathog Dis. 2015 Feb;73(1):1-9. doi: 10.1093/femspd/ftu028. Epub 2015 Jan 11.

44.

High-resolution multilocus sequence typing reveals novel urogenital Chlamydia trachomatis strains in women in Mopani district, South Africa.

Versteeg B, Dubbink JH, Bruisten SM, McIntyre JA, Morré SA, Peters RP.

Sex Transm Infect. 2015 Nov;91(7):510-2. doi: 10.1136/sextrans-2014-051998. Epub 2015 Mar 6.

PMID:
25746042
45.

Prevalence and macrolide resistance of Mycoplasma genitalium in South African women.

Hay B, Dubbink JH, Ouburg S, Le Roy C, Pereyre S, van der Eem L, Morré SA, Bébéar C, Peters RP.

Sex Transm Dis. 2015 Mar;42(3):140-2. doi: 10.1097/OLQ.0000000000000246.

PMID:
25668646
46.

Host factors and genetic susceptibility to infections due to intracellular bacteria and fastidious organisms.

Asner SA, Morré SA, Bochud PY, Greub G.

Clin Microbiol Infect. 2014 Dec;20(12):1246-53. doi: 10.1111/1469-0691.12806. Epub 2014 Dec 18. Review.

47.

Evaluation of the presence and zoonotic transmission of Chlamydia suis in a pig slaughterhouse.

De Puysseleyr K, De Puysseleyr L, Dhondt H, Geens T, Braeckman L, Morré SA, Cox E, Vanrompay D.

BMC Infect Dis. 2014 Oct 30;14:560. doi: 10.1186/s12879-014-0560-x.

48.

Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands.

van Rooijen MS, van der Loeff MF, Morré SA, van Dam AP, Speksnijder AG, de Vries HJ.

Sex Transm Infect. 2015 May;91(3):157-64. doi: 10.1136/sextrans-2014-051633. Epub 2014 Sep 18.

PMID:
25237127
49.

Cross-sectional study of genital, rectal, and pharyngeal Chlamydia and gonorrhea in women in rural South Africa.

Peters RP, Dubbink JH, van der Eem L, Verweij SP, Bos ML, Ouburg S, Lewis DA, Struthers H, McIntyre JA, Morré SA.

Sex Transm Dis. 2014 Sep;41(9):564-9. doi: 10.1097/OLQ.0000000000000175.

PMID:
25118973
50.

Genetic similarities between tobacco use disorder and related comorbidities: an exploratory study.

de Viron S, Morré SA, Van Oyen H, Brand A, Ouburg S.

BMC Med Genet. 2014 Jul 24;15:85. doi: 10.1186/1471-2350-15-85.

Supplemental Content

Loading ...
Support Center